Diabetic Nephropathy without Diabetes

被引:9
作者
Lopez-Revuelta, Katia [1 ]
Mendez Abreu, Angel A. [1 ]
Gerrero-Marquez, Carmen [2 ]
Stanescu, Ramona-Ionela [2 ]
Martinez Marin, Maria Isabel [1 ]
Perez Fernandez, Elia [3 ]
机构
[1] Hosp Univ Fdn Alcorcon, Unidad Nefrol, C Budapest 1, Madrid 28922, Spain
[2] Hosp Univ Fdn Alcorcon, Unidad Anatomia Patol, Madrid 28922, Spain
[3] Hosp Univ Fdn Alcorcon, Unidad Invest, Madrid 28922, Spain
关键词
diabetic nephropathy; idiopathic nodular glomerulosclerosis; hypertension; insulin resistance; IDIOPATHIC NODULAR GLOMERULOSCLEROSIS; CHRONIC KIDNEY-DISEASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; HYPERTENSIVE NEPHROSCLEROSIS; AFRICAN-AMERICANS; BASEMENT-MEMBRANE; BLOOD-PRESSURE; OBESITY; RISK;
D O I
10.3390/jcm4071403
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy without diabetes (DNND), previously known as idiopathic nodular glomerulosclerosis, is an uncommon entity and thus rarely suspected; diagnosis is histological once diabetes is discarded. In this study we describe two new cases of DNND and review the literature. We analyzed all the individualized data of previous publications except one series of attached data. DNND appears to be favored by recognized cardiovascular risk factors. However, in contrast with diabetes, apparently no factor alone has been demonstrated to be sufficient to develop DNND. Other factors not considered as genetic and environmental factors could play a role or interact. The most plausible hypothesis for the occurrence of DNND would be a special form of atherosclerotic or metabolic glomerulopathy than can occur with or without diabetes. The clinical spectrum of cardiovascular risk factors and histological findings support this theory, with hypertension as one of the characteristic clinical features.
引用
收藏
页码:1403 / 1427
页数:25
相关论文
共 52 条
[1]  
ALPERS CE, 1989, CLIN NEPHROL, V32, P68
[2]  
Altiparmak MR, 2002, NETH J MED, V60, P260
[3]  
[Anonymous], 2000, APPL SOCIAL RES METH
[4]   Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies [J].
Barba, C ;
Cavalli-Sforza, T ;
Cutter, J ;
Darnton-Hill, I ;
Deurenberg, P ;
Deurenberg-Yap, M ;
Gill, T ;
James, P ;
Ko, G ;
Miu, AH ;
Kosulwat, V ;
Kumanyika, S ;
Kurpad, A ;
Mascie-Taylor, N ;
Moon, HK ;
Nishida, C ;
Noor, MI ;
Reddy, KS ;
Rush, E ;
Schultz, JT ;
Seidell, J ;
Stevens, J ;
Swinburn, B ;
Tan, K ;
Weisell, R ;
Wu, ZS ;
Yajnik, CS ;
Yoshiike, N ;
Zimmet, P .
LANCET, 2004, 363 (9403) :157-163
[5]   Meta-analysis of prevalence [J].
Barendregt, Jan J. ;
Doi, Suhail A. ;
Lee, Yong Yi ;
Norman, Rosana E. ;
Vos, Theo .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2013, 67 (11) :974-978
[6]   Response to comment on: American Diabetes Association. Standards of medical care in diabetes-2011 (vol 34, pg e54, 2011) [J].
Wysham, C. H. ;
Kirkman, M. S. .
DIABETES CARE, 2011, 34 (08) :1887-1887
[7]   Nodular glomerulosclerosis with anti-glomerular basement membrane-like glomerulonephritis; a distinct pattern of kidney injury observed in smokers [J].
Batal, Ibrahim ;
Reyes, Daisy B. ;
Popham, Sandy ;
Bijol, Vanesa .
CLINICAL KIDNEY JOURNAL, 2014, 7 (04) :361-366
[8]   The human peroxisome proliferator-activated receptor γ2 (PPARγ2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes [J].
Caramori, ML ;
Canani, LH ;
Costa, LA ;
Gross, JL .
DIABETES, 2003, 52 (12) :3010-3013
[9]  
Chang CS, 2005, CLIN NEPHROL, V64, P300
[10]   Insulin resistance and risk of chronic kidney disease in nondiabetic US adults [J].
Chen, J ;
Muntner, P ;
Hamm, LL ;
Fonseca, V ;
Bautman, V ;
Whelton, PK ;
He, J .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (02) :469-477